Region: Global
Category: Medical Devices

Global Medical Devices

(14,499 reports matching your criteria)
  • Hip Replacement Implants

    ... at a CAGR of 3.5% over the analysis period 2024-2030. Total Hip Replacement Implant, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$8.6 Billion by the ... Read More

  • Hybrid Operating Rooms

    ... at a CAGR of 12.2% over the analysis period 2024-2030. Cardiovascular, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$1.2 Billion by the end of the ... Read More

  • Joint Reconstruction Devices

    ... at a CAGR of 6.3% over the analysis period 2024-2030. Knee Replacement, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$23.0 Billion by the end of ... Read More

  • Medical Equipment Maintenance

    ... at a CAGR of 9.1% over the analysis period 2024-2030. Diagnostic Imaging Equipment, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$32.9 Billion by the end ... Read More

  • Medical Device Testing

    ... at a CAGR of 5.5% over the analysis period 2024-2030. In-Vitro Diagnostics (IVD) Medical Devices, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$5.0 Billion by ... Read More

  • Peritoneal Dialysis

    ... CAGR of 5.7% over the analysis period 2024-2030. Continuous Ambulatory Peritoneal Dialysis (CAPD), one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$3.5 Billion by the end ... Read More

  • Self-Care Medical Devices

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Blood Glucose Monitors, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$34.8 Billion by the end ... Read More

  • Injection Pens

    ... CAGR of 5.9% over the analysis period 2024-2030. Disposable, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end of the analysis period. ... Read More

  • Intrauterine Devices

    ... CAGR of 3.8% over the analysis period 2024-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the ... Read More

  • Minimally Invasive Surgical Instruments

    ... 2030, growing at a CAGR of 6.0% over the analysis period 2024-2030. Handheld Instruments, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$9.8 Billion by the ... Read More

  • Cochlear Implants

    ... CAGR of 7.6% over the analysis period 2024-2030. Unilateral, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$2.9 Billion by the end of the analysis period. ... Read More

  • Orthopedic Surgical Robots

    ... at a CAGR of 40.2% over the analysis period 2024-2030. Knee Surgery, one of the segments analyzed in the report, is expected to record a 37.6% CAGR and reach US$6.6 Billion by the end of ... Read More

  • Healthcare Supply Chain Management

    ... 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Software, one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$2.3 Billion by the end ... Read More

  • Heart Valve Repair and Replacement Devices

    ... reach US$43.1 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2024-2030. Replacement Devices, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach ... Read More

  • Heart Pump Devices

    ... at a CAGR of 17.4% over the analysis period 2024-2030. Ventricular Assist Devices (VADs), one of the segments analyzed in the report, is expected to record a 19.1% CAGR and reach US$5.1 Billion by the ... Read More

  • Hip Reconstruction Devices

    ... at a CAGR of 4.5% over the analysis period 2024-2030. Primary Hip Replacement Hip Reconstruction Devices, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$10.1 Billion ... Read More

  • Microwave Ablation

    ... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the analysis ... Read More

  • Wheelchair Accessible Vehicle Converters

    ... 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Vans, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$7.2 Billion by the end ... Read More

  • Drug-Eluting Stents

    ... CAGR of 5.8% over the analysis period 2024-2030. Polymer-Free, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$7.9 Billion by the end of the analysis period. ... Read More

  • Trauma Devices

    ... CAGR of 5.4% over the analysis period 2024-2030. Internal Fixators, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$14.9 Billion by the end of the analysis ... Read More

  • Cardiac Biomarkers

    ... CAGR of 7.3% over the analysis period 2024-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$11.2 Billion by the end of ... Read More

  • Amniocentesis Needles

    ... CAGR of 2.1% over the analysis period 2024-2030. 150 mm & Above, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end of ... Read More

  • Anesthesia Monitoring Devices

    ... at a CAGR of 8.5% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$3.2 Billion by the end ... Read More

  • Disabled and Elderly Assistive Technology

    ... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Communication Aids, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$16.3 Billion ... Read More

  • Autologous Matrix-Induced Chondrogenesis (AMIC)

    ... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Collagen, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$175.6 Million by the end ... Read More

Cookie Settings